United Kingdom, Oct. 27 -- United Kingdom based Roche Products Ltd has secured contract from The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) for NP47725a Emicizumab (Indication Specific). The value of the contract is worth 3120312 GBP.
Published by HT Digital Content Services with permission from Pivotal Sources....